Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 3 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Board of Ipca Laboratories recommends final dividend
29 - May - 2025 12:00 | 3 days ago
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Board of Ipca Laboratories recommends final dividend
29 - May - 2025 12:00 | 3 days ago
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland
02 - May - 2025 12:00 | 30 days ago
Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Laboratories, Ireland is transferred to Ipca Laboratories and, therefore, Unichem Laboratories, Ireland has now become a wholly owned subsidiary of the Company.
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 3 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Board of Ipca Laboratories recommends final dividend
29 - May - 2025 12:00 | 3 days ago
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland
02 - May - 2025 12:00 | 30 days ago
Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Laboratories, Ireland is transferred to Ipca Laboratories and, therefore, Unichem Laboratories, Ireland has now become a wholly owned subsidiary of the Company.
Ipca Laboratories consolidated net profit rises 13.81% in the March 2025 quarter
29 - May - 2025 12:00 | 3 days ago
Net profit of Ipca Laboratories rose 13.81% to Rs 67.82 crore in the quarter ended March 2025 as against Rs 59.59 crore during the previous quarter ended March 2024. Sales rose 10.51% to Rs 2246.69 crore in the quarter ended March 2025 as against Rs 2033.03 crore during the previous quarter ended March 2024.
For the full year,net profit rose 34.77% to Rs 737.68 crore in the year ended March 2025 as against Rs 547.35 crore during the previous year ended March 2024. Sales rose 16.02% to Rs 8939.59 crore in the year ended March 2025 as against Rs 7705.04 crore during the previous year ended March 2024.
Board of Ipca Laboratories recommends final dividend
29 - May - 2025 12:00 | 3 days ago
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Board of Ipca Laboratories recommends final dividend
29 - May - 2025 12:00 | 3 days ago
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.
Ipca Laboratories now holds 100% stake in Unichem Laboratories, Ireland
02 - May - 2025 12:00 | 30 days ago
Ipca Laboratories announced that 100% of the paid-up equity share capital of Unichem Laboratories, Ireland is transferred to Ipca Laboratories and, therefore, Unichem Laboratories, Ireland has now become a wholly owned subsidiary of the Company.
